The World Health Organization convened its International Health Regulations Emergency Committee for the second time this month to address a worsening outbreak of Ebola Bundibugyo virus disease in the Democratic Republic of the Congo, according to WHO announcements. The decision to hold consecutive emergency sessions underscores mounting concern about a strain of Ebola that is less well-studied and harder to detect than its more notorious cousin, Ebola Zaire.

The Bundibugyo strain, first identified in Uganda in 2007, accounts for only a fraction of recorded Ebola outbreaks but carries a case fatality rate between 30 and 40 percent. Unlike Ebola Zaire — the strain responsible for the devastating 2014-2016 West Africa epidemic — Bundibugyo has no approved vaccine, complicating response efforts in a region already strained by decades of conflict and fragile health infrastructure.

A Familiar Crisis in Unfamiliar Territory

The current outbreak is centered in eastern DRC, a patchwork of provinces where armed groups control territory and displacement is routine. Health officials have not disclosed the exact number of confirmed cases, but the decision to reconvene the Emergency Committee suggests case counts or geographic spread have exceeded initial projections.

"The DRC has faced more Ebola outbreaks than any other country, but each one presents unique challenges," said Dr. Michel Yao, WHO's Emergency Response Coordinator for Africa, in previous statements about viral hemorrhagic fevers in the region. "When you're dealing with Bundibugyo in areas where people move frequently to escape violence, traditional contact tracing becomes exponentially more difficult."

The Emergency Committee, composed of international public health experts, infectious disease specialists, and ethicists, operates under the International Health Regulations framework established in 2005. Its role is to advise the WHO Director-General on whether an outbreak constitutes a Public Health Emergency of International Concern — a designation that mobilizes resources and imposes certain obligations on member states.

Temporary Recommendations Signal Urgency

Following the second meeting, the committee issued what WHO terms "temporary recommendations" — a set of measures intended to guide both the affected country and the international community. While the specific content of these recommendations has not been fully detailed in public statements, such guidance typically addresses surveillance protocols, cross-border screening measures, and research priorities.

The fact that recommendations are labeled "temporary" reflects the fluid nature of outbreak response. As epidemiological patterns shift or interventions prove effective — or inadequate — the committee may revise its guidance. The召开 of a second meeting within weeks suggests initial measures may need strengthening or that the outbreak's trajectory has changed.

Bundibugyo's relative rarity means diagnostic capacity remains limited. Standard rapid tests designed for Ebola Zaire may not reliably detect Bundibugyo, requiring samples to be sent to specialized laboratories — a process that can take days in remote areas. This diagnostic gap creates dangerous delays in isolating patients and tracing their contacts.

The Shadow of Past Outbreaks

The DRC's experience with Ebola is both an asset and a burden. Health workers in the eastern provinces have lived through multiple outbreaks since 2018, developing hard-won expertise in infection prevention and community engagement. Yet that same history has bred fatigue and, in some communities, deep mistrust of outside health interventions.

During the 2018-2020 outbreak in North Kivu and Ituri provinces — the second-largest Ebola epidemic on record — response teams faced armed attacks, and misinformation spread faster than the virus itself. Some communities, scarred by years of exploitation and broken promises, viewed Ebola treatment centers with suspicion. Health workers were sometimes perceived as agents of a distant government or foreign interests rather than allies in a shared crisis.

The current outbreak unfolds against a similarly complex backdrop. Militia violence continues to displace thousands, and the Congolese health system — chronically underfunded and stretched thin by malaria, cholera, measles, and malnutrition — operates in a state of perpetual emergency.

What Comes Next

The Emergency Committee's recommendations will likely emphasize the need for sustained international support, both financial and technical. Without a licensed vaccine for Bundibugyo, response efforts must rely on time-tested but labor-intensive measures: meticulous contact tracing, safe burial practices, community health education, and rigorous infection control in health facilities.

Research into therapeutics and vaccines for Bundibugyo has lagged behind efforts targeting Ebola Zaire, in part because outbreaks have been smaller and less frequent. The current crisis may renew calls for broader investment in preparedness for all Ebola strains, not just the most common.

For now, Congolese health authorities and their international partners face a race against geography, insecurity, and a virus that has claimed lives quietly for nearly two decades. The Emergency Committee's decision to meet again so soon is a reminder that in outbreak response, vigilance and adaptation are not optional — they are the only path forward.